Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Gondouin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen PatientsMarie Jachiet, Maxime Samson, Vincent Cottin, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
Respirology (Carlton, Vic.)|January 4, 2022
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective studyQuentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, et al.
Autoimmunity Reviews|September 28, 2016
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
The European Respiratory Journal|September 3, 2016
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
Respiratory Medicine|May 9, 2021
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncoverLucile Sesé, Julien Caliez, Isabella Annesi-Maesano, et al.
The European Respiratory Journal|November 20, 2020
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutationAurélien Justet, Dymph Klay, Raphaël Porcher, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
The European Respiratory Journal|August 29, 2020
Functional assessment and phenotypic heterogeneity of <i>SFTPA1</i> and <i>SFTPA2</i> mutations in interstitial lung diseases and lung cancerMarie Legendre, Afifaa Butt, Raphaël Borie, et al.
Respiratory Medicine and Research|January 11, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length versionVincent Cottin, Philippe Bonniaud, Jacques Cadranel, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen PatientsMarie Jachiet, Maxime Samson, Vincent Cottin, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
Respirology (Carlton, Vic.)|January 4, 2022
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective studyQuentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, et al.
Autoimmunity Reviews|September 28, 2016
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
The European Respiratory Journal|September 3, 2016
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
Respiratory Medicine|May 9, 2021
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncoverLucile Sesé, Julien Caliez, Isabella Annesi-Maesano, et al.
The European Respiratory Journal|November 20, 2020
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutationAurélien Justet, Dymph Klay, Raphaël Porcher, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
The European Respiratory Journal|August 29, 2020
Functional assessment and phenotypic heterogeneity of <i>SFTPA1</i> and <i>SFTPA2</i> mutations in interstitial lung diseases and lung cancerMarie Legendre, Afifaa Butt, Raphaël Borie, et al.
Respiratory Medicine and Research|January 11, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length versionVincent Cottin, Philippe Bonniaud, Jacques Cadranel, et al.
Pageof 3